Loading...

Urologix, Inc.

ULGXPNK
Healthcare
Medical - Devices
$0.00
$-0.00(-0.00%)

Urologix, Inc. (ULGX) Stock Competitors & Peer Comparison

See (ULGX) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Devices Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
ULGX$0.00-0.00%2.2K-0.01-$0.01N/A
SMMNY$28.04+1.08%125.9B25.99$1.08+1.05%
SEMHF$56.90+5.32%63.8B26.34$2.16+1.74%
RYLPF$26.01+9.07%24.7B86.70$0.30+3.65%
SONVF$299.78+5.28%17.9B26.58$11.28+1.74%
SONVY$58.85-1.13%17.6B26.06$2.26+1.07%
CHEOY$102.47-0.67%13.4B55.69$1.84+1.36%
SNNUF$14.94+1.29%13.1B31.79$0.47+2.51%
CHEOF$193.04+0.00%12.6B52.31$3.69+1.44%
WILYY$20.19+0.00%9B19.41$1.04N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

ULGX vs SMMNY Comparison July 2025

ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ULGX stands at 2.2K. In comparison, SMMNY has a market cap of 125.9B. Regarding current trading prices, ULGX is priced at $0.00, while SMMNY trades at $28.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ULGX currently has a P/E ratio of -0.01, whereas SMMNY's P/E ratio is 25.99. In terms of profitability, ULGX's ROE is +2.32%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, ULGX is less volatile compared to SMMNY. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check SMMNY's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;